ArticleJournal of cellular and molecular medicine2024

Pan-cancer analysis identifies the IRF family as a biomarker for survival prognosis and immunotherapy.

Hua-Guo Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.